Skip to content
2000
Volume 31, Issue 31
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Introduction

Neuropathy caused by chemotherapy, a dose-limiting neurotoxic side effect, often leads to treatment discontinuation. About 30 to 70% of patients treated with paclitaxel experience peripheral neuropathy due to the drug combination and dosage. Given the significant prevalence of neuropathy in individuals who have undergone chemotherapy treatments and the growing need for new therapeutic approaches, including those based on natural resources, it is imperative to investigate substances capable of mitigating this adverse effect.

Methods

Natural plant compounds are often used to treat various pathological conditions due to superior treatment options and minimal side effects. Rose oxide (RO), monoterpenes present in several essential oils, have demonstrated anti-inflammatory activity by inhibiting IL-1β production and leukocyte migration. Therefore, the present study aimed to investigate the effect of rose oxide in its free form on animal models of neuropathic pain induced by antineoplastics in rats. Neuropathic pain was induced by paclitaxel at a dose of 20 mg/kg i.p. for four consecutive days and treated with rose oxide at doses of 12.5, 25, and 50 mg/kg and after this period, behavioral analyzes (von Frey mechanical allodynia, acetone test and open field), biochemical, hematological and assessment of oxidative stress (malondialdehyde levels). The results suggested that rose oxide has antinociceptive activity in animal models of antineoplastic-induced neuropathic pain in rats.

Results

Furthermore, treatment with RO did not show significant adverse effects on biochemical and hematological parameters, with the exception of the 12.5 mg/kg dose of RO affected creatinine levels and all doses of TGP, while the highest dose (50 mg/kg) caused changes in total proteins and albumin, suggesting a more binding strong with plasma proteins. Finally, treatment with RO 25 mg/kg significantly altered malondialdehyde (MDA) levels.

Conclusion

These results suggest that the use of RO in its free form may be a promising option for the treatment of antineoplastic-induced neuropathic pain in humans. However, further studies are needed to confirm these findings and evaluate safety and efficacy.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128327126250220093640
2025-02-28
2025-10-25

  • From This Site

    /content/journals/cpd/10.2174/0113816128327126250220093640
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. JordanM.A. WilsonL. Microtubules as a target for anticancer drugs.Nat. Rev. Cancer20044425326510.1038/nrc1317 15057285
     [Google Scholar]
  2. DranitsarisG. KingJ. KauraS. YuB. ZhangA. Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: A cost-utility analysis from a Chinese health care perspective.Clinicoecon. Outcomes Res.2015724925610.2147/CEOR.S82194 25999749
     [Google Scholar]
  3. ParkS.B. LinC.S.Y. KrishnanA.V. FriedlanderM.L. LewisC.R. KiernanM.C. Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel‐induced neuropathy.Muscle Nerve201143336737410.1002/mus.21874 21321953
     [Google Scholar]
  4. LeesJ.G. MakkerP.G.S. TonkinR.S. Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy.Eur. J. Cancer201773222910.1016/j.ejca.2016.12.006 28104535
     [Google Scholar]
  5. MakkerP.G.S. DuffyS.S. LeesJ.G. Characterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy.PLoS One2017121e017081410.1371/journal.pone.0170814 28125674
     [Google Scholar]
  6. MeyerR.A. RingkampM. RajaS.N. CampbellJ.N. Peripheral mechanisms of cutaneous nociception.Wall and Melzack’s Textbook of Pain.6th ed202333410.1016/B0‑443‑07287‑6/50006‑0
     [Google Scholar]
  7. JanesK. LittleJ.W. LiC. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.J. Biol. Chem.201428930210822109710.1074/jbc.M114.569574 24876379
     [Google Scholar]
  8. ChaudhryV. RowinskyE.K. SartoriusS.E. DonehowerR.C. CornblathD.R. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies.Ann. Neurol.199435330431110.1002/ana.410350310 7907208
     [Google Scholar]
  9. RaoR.D. MichalakJ.C. SloanJ.A. Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy.Cancer200711092110211810.1002/cncr.23008 17853395
     [Google Scholar]
  10. KautioA.L. HaanpääM. SaartoT. KalsoE. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.J. Pain Symptom Manage.2008351313910.1016/j.jpainsymman.2007.02.043 17980550
     [Google Scholar]
  11. NewmanD.J. CraggG.M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019.J. Nat. Prod.202083377080310.1021/acs.jnatprod.9b01285 32162523
     [Google Scholar]
  12. YuanC. ZhangW. WangJ. Chinese medicine phenomics (Chinmedphenomics): Personalized, precise and promising.Phenomics20222638338810.1007/s43657‑022‑00074‑x
     [Google Scholar]
  13. WangX. LiuX. ShiK. Blinding assessment in clinical trials of traditional Chinese medicine: Exploratory principles and protocol.J. Integr. Med.202321652853610.1016/j.joim.2023.10.003 37957088
     [Google Scholar]
  14. KumarG.P. KhanumF. Neuroprotective potential of phytochemicals.Pharmacogn. Rev.2012612819010.4103/0973‑7847.99898 23055633
     [Google Scholar]
  15. OnkenJ. BergerR.G. Biotransformation of citronellol by the basidiomycete Cystoderma carcharias in an aerated-membrane bioreactor.Appl. Microbiol. Biotechnol.199951215816310.1007/s002530051376 10091320
     [Google Scholar]
  16. WüstM. FuchsS. RexrothA. BeckT. MosandlA. Fragmentation mechanism of rose oxide in electron impact mass spectrometry.Eur. J. Mass Spectrom. (Chichester, Eng.)19984116316610.1255/ejms.204
     [Google Scholar]
  17. NonatoF.R. SantanaD.G. de MeloF.M. Anti-inflammatory properties of rose oxide.Int. Immunopharmacol.201214477978410.1016/j.intimp.2012.10.015 23122727
     [Google Scholar]
  18. OhtsuboS. FujitaT. MatsushitaA. KumamotoE. Inhibition of the compound action potentials of frog sciatic nerves by aroma oil compounds having various chemical structures.Pharmacol. Res. Perspect.201532113
     [Google Scholar]
  19. MaiaW.M.N. De AndradeF.D.C.P. FilgueirasL.A. Antidepressant activity of rose oxide essential oil: Possible involvement of serotonergic transmission.Heliyon202174e0662010.1016/j.heliyon.2021.e06620
     [Google Scholar]
  20. AghiliM. ZareM. MousaviN. Efficacy of gabapentin for the prevention of paclitaxel induced peripheral neuropathy: A randomized placebo controlled clinical trial.Breast J.201925222623110.1111/tbj.13196 30773731
     [Google Scholar]
  21. RahmanM. SonM. KimH. DHP107, a novel oral paclitaxel formulation induces less peripheral neuropathic pain and pain-related molecular alteration than intravenous paclitaxel preparation in rat.J Adv Biotechnol Exp Ther201922110.5455/jabet.2019.d26
     [Google Scholar]
  22. OhkawaH. OhishiN. YagiK. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.Anal. Biochem.197995235135810.1016/0003‑2697(79)90738‑3 36810
     [Google Scholar]
  23. StageT.B. BergmannT.K. KroetzD.L. Clinical pharmacokinetics of paclitaxel monotherapy: An updated literature review.Clin. Pharmacokinet.201857171910.1007/s40262‑017‑0563‑z 28612269
     [Google Scholar]
  24. ColvinL.A. Chemotherapy-induced peripheral neuropathy: Where are we now?Pain20191601Suppl. 1S1S1010.1097/j.pain.0000000000001540 31008843
     [Google Scholar]
  25. XuY. JiangZ. ChenX. Mechanisms underlying paclitaxel-induced neuropathic pain: Channels, inflammation and immune regulations.Eur. J. Pharmacol.202293317528810.1016/j.ejphar.2022.175288 36122757
     [Google Scholar]
  26. DuggettN.A. GriffithsL.A. FlattersS.J.L. Paclitaxel-induced painful neuropathy is associated with changes in mitochondrial bioenergetics, glycolysis, and an energy deficit in dorsal root ganglia neurons.Pain201715881499150810.1097/j.pain.0000000000000939 28541258
     [Google Scholar]
  27. StaffN.P. FehrenbacherJ.C. CaillaudM. DamajM.I. SegalR.A. RiegerS. Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems.Exp. Neurol.202032411312110.1016/j.expneurol.2019.113121 31758983
     [Google Scholar]
  28. KleinI. LehmannH. Pathomechanisms of paclitaxel-induced peripheral neuropathy.Toxics202191022910.3390/toxics9100229 34678925
     [Google Scholar]
  29. SeibenhenerM.L. WootenM.C. Use of the open field maze to measure locomotor and anxiety-like behavior in mice.J. Vis. Exp.2015696e52434 25742564
     [Google Scholar]
  30. LippoldtE.K. OngunS. KusakaG.K. McKemyD.D. Inflammatory and neuropathic cold allodynia are selectively mediated by the neurotrophic factor receptor GFRα3.Proc. Natl. Acad. Sci. USA2016113164506451110.1073/pnas.1603294113 27051069
     [Google Scholar]
  31. VincentJ-L. Annual update in intensive care and emergency medicine 2012.1st edBerlin, HeidelbergSpringer Berlin Heidelberg2012
     [Google Scholar]
  32. JagiełaJ. BartnickiP. RyszJ. Nephrotoxicity as a complication of chemotherapy and immunotherapy in the treatment of colorectal cancer, melanoma and non-small cell lung cancer.Int. J. Mol. Sci.2021229461810.3390/ijms22094618 33924827
     [Google Scholar]
  33. CostaM.L. RodriguesJ.A. AzevedoJ. VasconcelosV. EirasE. CamposM.G. Hepatotoxicity induced by paclitaxel interaction with turmeric in association with a microcystin from a contaminated dietary supplement.Toxicon201815020721110.1016/j.toxicon.2018.05.022
     [Google Scholar]
  34. PieniążekA. CzepasJ. Piasecka-ZelgaJ. GwoździńskiK. Koceva-ChyłaA. Oxidative stress induced in rat liver by anticancer drugs doxorubicin, paclitaxel and docetaxel.Adv. Med. Sci.201358110411110.2478/v10039‑012‑0063‑1 23612702
     [Google Scholar]
  35. NyarotaK. ZhouD.T. Albumin and total protein in cancer patients at radiotherapy clinic, Zimbabwe.Saudi J Med Pharm Sci201731010711076
     [Google Scholar]
  36. YinW. MingZ. LiuQ. Resistance distance and Kirchhoff index for a class of graphs.Math. Probl. Eng.2018201818, 2610.1155/2018/1028614
     [Google Scholar]
  37. WangJ. FregosoG. WangA. TsengK. Transition from acute to chronic pain: Evaluating risk for chronic postsurgical pain.Pain Physician2019225479488 31561647
     [Google Scholar]
  38. ValentP. Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.Blood Rev.200923415716510.1016/j.blre.2009.01.001 19246139
     [Google Scholar]
  39. AraújoD.F.B. CavalcantiI.D.L. Larrazabal-Hadj-IdrisB.R. PeresA.L. Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer.J. Bras. Patol. Med. Lab.202010.5935/1676‑2444.20200038
     [Google Scholar]
/content/journals/cpd/10.2174/0113816128327126250220093640
Loading
Investigation of the Effect of Rose Oxide in Animal Models of Paclitaxel-induced Neuropathic Pain in Rats
Curr. Pharm. Des. 31, 2525 (2025); https://doi.org/10.2174/0113816128327126250220093640
/content/journals/cpd/10.2174/0113816128327126250220093640
/content/journals/cpd/10.2174/0113816128327126250220093640
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): adverse effect; antineoplastic; Biochemical analyses; monoterpene; paclitaxel; rose oxide

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test